Longitudinal Study of Xenon-129 MRI Imaging Effects of Cannabis Smoking
Recruiting now NCT03909477
Run by Western University, Canada · for 18 to 85 · All sexes · accepts healthy volunteers
What this study is about
This is a longitudinal study of the long-term health impact of cannabis smoking on the lungs. Participants will be followed over a period of 3 years, and impacts of cannabis smoking on the lungs will be measured with magnetic resonance imaging (MRI) using hyperpolarized xenon-129 gas, pulmonary function tests, exercise capacity, computed tomography images and questionnaires.
Who can join (things the study team will check)
✅ You may be able to join if…
- Patient understands study procedures and is willing to participate in the study as indicated by the patient's signature
- Provision of written, informed consent prior to any study specific procedures
- Males and females aged 18-85
- Current or former cannabis smoker (medicinal or recreational) with or without concurrent tobacco smoking history
- Participant is able to perform reproducible pulmonary function testing (i.e. the 3 best acceptable spirograms have Forced Expiratory Volume in 1 second (FEV1) values that do not vary more than 150 millilitres)
- Participant is able to perform a breathhold for 16s
- FEV1 > 25% predicted
- Forced Vital Capacity (FVC) > 25% predicted and >0.5 litres
🚫 You may not be able to join if…
- Participant is, in the opinion of the investigator, mentally or legally incapacitated, preventing informed consent from being obtained, or cannot read or understand written material
- Participant is medically unstable in the opinion of the Principal Investigator
- Participant has a daytime room air oxygen saturation <90% while lying supine
- Participant is unable to perform spirometry or plethysmography maneuvers
- Patient is pregnant at time of enrolment
- In the opinion of the investigator, patient suffers from any physical, psychological or other condition(s) that might prevent performance of the MRI, such as severe claustrophobia
- Patient has implanted mechanically, electrically or magnetically activated device or any metal in their body, which cannot be removed, including but not limited to pacemakers, neurostimulators, biostimulators, implanted insulin pumps, aneurysm clips, bioprosthesis, artificial limb, metallic fragment or foreign body, shunt, surgical staples (including clips or metallic sutures and/or ear implants) - at the discretion of the MRI Technologist.
Where this trial is running
- Robarts Research Institute; The University of Western Ontario; London Health Sciences Centre, London, Ontario, Canada
Who to contact
Grace E Parraga, PhD · 519-931-5265 · gparraga@uwo.ca
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT03909477.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.
Beacon is an information tool, not medical advice. Whether a trial is right for you is a decision for you, your doctor, and the study team. Trial details come from the official registry, ClinicalTrials.gov, and may change — always confirm with the study team. Beacon collects no data about you: this page has no cookies, no accounts, and no tracking.